- Home
- Drug Product Development
Drug Product Development
![](https://adragos-pharma.com/wp-content/uploads/2024/03/3Q4A7625.jpg)
Drug Product Development
We specialize in drug development of complex molecules, including new chemical entities, value-added medicines, and both generic and generic plus products. Our offerings include out-licensing, supply chain solutions, specialized analysis, custom developments, and formulation services. We have a refined drug product development process, ensuring timely delivery within budgetary constraints.
Adopting a multidisciplinary approach, our pharmaceutical formulation and development process integrate advanced analytical techniques, manufacturing technologies, and principles of Quality by Design (QbD) and Quality Risk Management (QRM) at every stage of the drug product development.
The HPAPI Laboratory is equipped to safely manage High Potency Active Pharmaceutical Ingredients (HPAPI) with an Occupational Exposure Limit (OEL) not lower than 0.5 μg/m³.
Our state-of-the-art laboratories offer extensive analytical services to meet clients’ specific needs. We follow strict quality procedures, GMP requirements, and ICH Guidelines, essential in the drug product development process.
⟶We provide clinical development for New Chemical Entities (NCEs), value-based medicines, and generics. We help clients navigate the complex landscape of drug development, proposing the optimal plan for success.
Our experts handle regulatory activities to achieve approved dossiers. We provide support in submission processes and documentation management throughout the drug development process, ensuring compliance with latest international regulations.
⟶Our Approach
We offer tailor-made drug development services, from out-licensing to custom developments and formulation services. Our streamlined drug product development process ensures smooth progress from start to finish, keeping each project on schedule and within budget. Whether you’re looking for a co-development model, prefer licensing and royalty agreements, or seek a straightforward fee-for-service arrangement, we have the flexibility to accommodate your requirements.
Quality by Design
QbD is integral to every drug product development process we undertake. Applying QbD ensures consistent development of high-quality pharmaceutical products that exceed industry benchmarks, while complying with regulatory standards.
U.S. FDA- Compliant Drug Development
Since 2022, we comply with U.S. FDA regulations for drug development services. Our team manages also the development of new product applications, including ANDA and 505(b)(2), specifically for the U.S. market.
Our Services
We specialise in the development of New Chemical Entities (NCE), Value Added Medicines (VAMs) and generics. Our experienced team of over 60 scientists drives successful outcomes in the drug development process.
Formulation Development
- API characterization
- Preformulation
- Formulation development
- Analytical method development
- Process development
- Technology transfer
- IP Search (Intellectual property)
Analytical Services
- Method development and validation
- Chemical compatibility
- Forced degradation
- Dissolution (USP I, II and III)
- Chemical analysis of APIs
- Finished product controls
- ICH stability, photostability and in-use stability
Scientific and Clinical Development
- Clinical strategy
- Study design and sample size calculation
- BCS Biowaivers
- Dissolution data analysis
- IVIVC
- Clinical trial project management
- Nonclinical and clinical overviews
- Scientific advice meetings
Regulatory Services
- Regulatory and registration strategy
- Scientific report writing
- Compilation and publishing of data in eCTD format
- Liaising with regulatory authorities
- Registration services and support
- Risk assessment reports
Meet our experts
Highly skilled and well-trained scientists focused on development.
Aggelos Karatzas
Site Head, Athens
John Kytariolos
Head of Clinical & Scientific Affairs, Athens
Konstantinos Apostolou
R&D Senior Manager, Athens
Argyro Stappa
Head of R&D, Athens
Amalia Stroumpou
Head of GMP Analytical/QP, Athens
Lenia Papadimou
Head of Regulatory Affairs, Athens
Christina Koulouri
Head of Project Management & Supply Chain, Athens